Securing a competitive advantage by specializing in analysis plans and shortening delivery times
First written in FY2017. 3 of 7 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「With a view to the digital biotechnology era accompanying future advances in AI, we will substantially upgrade high-sensitivity analysis to “ultra-high-sensitivity analysis” in order to further strengthen our technological competitiveness, and will seek to further shorten turnaround times for high-throughput analysis. We will also work to develop multi-omics analytical technologies compatible with a data-driven analytical method known as DIA, as well as library-free annotation technology that can identify substances without using reference-standard reagents.」
In addition to the existing productivity improvements, proprietary services and one-stop provision, the company has expanded its competitive measures to include ultra-high-sensitivity analysis, higher throughput, DIA-compatible multi-omics analysis and library-free annotation. - 2026-08-20RaisedFinancial Results Presentation
「• Ultra-high sensitivity • High throughput • Support for data-driven analysis」
The company identified ultra-high sensitivity, high throughput, and support for data-driven analysis as pillars of its response to competition and technological competitiveness. - FY2024RestatedAnnual report
「For contract metabolomics services, we are working to reduce costs by improving productivity and establish a profitable business structure with competitive pricing. For contract analytical services other than metabolomics, we are expanding primarily through analytical services developed in-house and working to maintain and strengthen our competitive advantage by providing one-stop analytical services and through other measures.」
We continue to address competition through cost reductions from productivity improvements, proprietary in-house services and one-stop provision. - FY2021ReframedAnnual report
「For contract metabolomics services, we are working to reduce costs by improving productivity and establish a profitable business structure with competitive pricing. For contract analytical services other than metabolomics, we are expanding primarily through analytical services developed in-house and working to maintain and strengthen our competitive advantage by providing one-stop analytical services and through other measures.」
In addition to the existing specialized analytical offerings and shorter turnaround times, the company has identified cost reductions through productivity improvements, proprietary analytical services and one-stop provision as competitive measures. - FY2020RestatedAnnual report
「Our group differentiates itself from competitors through specialized analytical offerings focused on analyzing energy metabolism in cancer cells, as well as shorter turnaround times.」
We continue to pursue a policy of securing a competitive advantage through specialized analytical offerings and shorter turnaround times. - FY2019RestatedAnnual report
「Our Group differentiates itself from competitors through analysis plans specializing in energy metabolism analysis of cancer cells and through shorter turnaround times.」
The company continues its policy of differentiation through specialized analysis plans and shorter turnaround times. - FY2017First statedAnnual report
「Our Group differentiates itself from competitors through analysis plans specializing in energy metabolism analysis of cancer cells and through shorter turnaround times.」
The company identifies specialization in energy metabolism analysis of cancer cells and shorter turnaround times as means of differentiating itself from competitors.